The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells
Open accessAbstract
Mice homozygous for the F759 mutation in the gp130 interleukin (IL)-6 receptor subunit have enhanced gp130-mediated signal transducer and activator of transcription (STAT)3 activation and spontaneously developed a lymphocyte-mediated rheumatoid arthritis-like joint disease. Here, we show that the development of the disease is dependent on both major histocompatibility complex (MHC) II–restricted CD4+ T cells and IL-6 family cytokines. In spite of the necessity for CD4+ T cells, the gp130 mutation was only required in nonhemtopoietic cells for the disease. The gp130 mutation resulted in enhanced production of IL-7. Conditional knockout of STAT3 in nonlymphoid cells showed that the enhancement of IL-7 production was dependent on STAT3 activation by IL-6 family cytokines. Homeostatic proliferation of CD4+ T cells was enhanced in gp130 mutant mice and acceleration of homeostatic proliferation enhanced the disease, whereas the inhibition of homeostatic proliferation suppressed the disease. Anti–IL-7 antibody treatment inhibited not only the enhanced homeostatic proliferation, but also the disease in gp130 mutant mice. Thus, our results show that autoimmune disease in gp130 mutant mice is caused by increased homeostatic proliferation of CD4+ T cells, which is due to elevated production of IL-7 by nonhematopoietic cells as a result of IL-6 family cytokine-gp130-STAT3 signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2. Increase in CD44highCD4+ T cells, lymphadenopathy, splenomegaly, and enhanced homeostatic proliferation in the periphery of F759. (A) FACS profiles of CD4+ T cells isolated from sLNs of F759 and control mice (8–10 mo old). These experiments were performed three times independently; representative data are shown. The percentage of CD44highCD4+ T cells (CD62Lhigh and CD62Llow) is shown with error bars indicating 1 SD. The p-value was calculated by Student's t test (*, P = 0.0000025). (B) CD44lowCD4+ T cells were sorted from C57BL/6/SJL mice, labeled with CFSE, and injected into irradiated wild type or C57BL/6/F759. FACS profiles of the CD45.1+CD4+T cells in the sLNs and spleen are shown. These experiments were performed five times independently and representative data are shown. The relative amount of CFSEhigh (most slowly dividing [A]), CFSEmiddle [B], and CFSElow (most rapidly dividing [C]) cells, with the value for CFSEhigh defined as 1, is shown with error bars indicating 1 SD. The p-value was calculated by Student's t test (*, P = 0.00037 and **, P = 0.000002). (C) CD44lowCD4+ T cells from C57BL/6/SJL were CFSE labeled and injected into nonthymectomized and N7Txed C57BL/6 or C57BL/6/F759 neonates. FACS profiles of CD45.1+CD4+ T cells from the sLNs and spleen are shown. These experiments were performed three times independently and representative data are shown. The relative amount of CFSEhigh (A), CFSEmiddle (B), and CFSElow (C) cells, with the value for CFSEhigh defined as 1, is shown with error bars indicating 1 SD. The p-value was calculated by Student's t test (*, P = 0.0017 and **, P = 0.0008). (D and E) The sLNs (D) and spleen (E) were from and the total cell numbers were calculated. The mean is shown with error bars indicating 1 SD. The p-value was calculated by Student's t test (*, P = 0.0042; **, P = 0.0038; ***, P = 0.00034; and ****, P = 0.00027). (F) The sLNs and spleen were harvested from NT7xed C57BL/6 and C56BL/6/F759. The numbers of CD4+ T cells were calculated from FACS analyses (open circles; N7Txed F759 and open triangles; N7Txed wild type). The mean is shown as open (N7Txed wild type) and closed (N7Txed F759) bars. The p-value was calculated by Student's t test (*, P = 0.0065; **, P = 0.0068; ***, P = 0.00034; and ****, P = 0.00021). (G) Neonatal thymectomy increased the CD44high memory/activated CD4+ T cells in the spleen of NTx F759. FACS profiles of CD4+ T cells isolated from the spleen of N7Txed or sham-N7Txed F759 and wild-type mice (2 wk old). These experiments were performed twice independently (total 12 samples each) and representative data are shown. The percentage of CD44highCD4+ T cells (CD62Lhigh and CD62Llow) is shown with error bars indicating 1 SD. The p-value was calculated by Student's t test (*, P = 0.024; **, P = 0.0032; ***, P = 0.00000039; and ****, P = 0.0000002).](/paper-figures/188a66d00d384f9988e15f876c66cb59/autoimmune-arthritis-associated-with-mutated-interleukin-il-6-receptor-gp130-is-figure-2.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further, they act on fibroblasts and endothelial cells to recruit T helper 17 (Th17) cells, leading to an RA-like joint disease (F759 arthritis) and experimental autoimmune encephalomyelitis (EAE) (54, 66, 99).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In fact, a mutated gp130-mediated excessive production of cytokines and chemokines in non-immune cells in F759 mice is necessary for CD4(+) T-cell proliferation, Th17 cell accumulation in the lesion and the arthritis development (66, 99).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although the development of F759 arthritis is dependent on Th17 cells, the F759 mutation is required in non-immune cells but not immune cells, clearly indicating that the interaction between non-immune cells and immune cells is crucial for arthritis development in F759 mice (66, 99).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [99]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although the development of F759 arthritis is dependent on Th17 cells, the F759 mutation is required in non-immune cells but not immune cells, clearly indicating that the interaction between non-immune cells and immune cells is crucial for arthritis development in F759 mice (66, 99).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,653 · cited 1×
“20052187 1459 Autoimmune diseases comprise a heterogeneous group of poorly understood disorders that are controlled by genetic and environmental factors (1, 2).”
BackgroundSakaguchi, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,315
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,507
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. M. (2003) · Science · doi:10.1126/science.1078231 · Cited by 2,000
Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements
Kontoyiannis, D. L., Pasparakis, M., Pizarro, T. T., Cominelli, F., & Kollias, G. A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80038-2 · Cited by 1,329
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.387 · Cited by 1,328 · cited 17×
“The relative amount of CFSEhigh (A), CFSEmiddle (B), and CFSElow (C) cells, with the value for CFSEhigh defi ned as 1, is shown with error bars indicating 1 SD. (D) Incidence of arthritis with a score >2.0 in N7Txed F759 plus saline (open circles, n = 14), N7Txed F759 plus i.p. injection of fi ller T cells (closed tri…”
BackgroundInfluentialSetoguchi, R., Hori, S., Takahashi, T., & Sakaguchi, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041982 · Cited by 1,234
IL-7 is critical for homeostatic proliferation and survival of naïve T cells
Tan, J. T., Dudl, E. P., LeRoy, E., Murray, R. M., Sprent, J., Weinberg, K. I., & Surh, C. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161126098 · Cited by 966 · cited 4×
“In fact, CD4+ T cell HP is signifi cantly impaired in MHCII- or IL-7–defi cient mice (12, 13).”
BackgroundInfluentialIL-6 in autoimmune disease and chronic inflammatory proliferative disease
Ishihara, K., & Hirano, T. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00027-8 · Cited by 807
Self-citationInterleukin 6 and its receptor: ten years later
Hirano, T. (1998) · International Reviews of Immunology · doi:10.3109/08830189809042997 · Cited by 788
Self-citation
Research works printed but not linked: 3
- 2004, J. Clin. Invest., 114, 582, 10.1172/JCI200421795 · DOI
- 2003, Nat. Immunol., 4, 891
- 2004, Blood., 104, 2794
Cited by
Sorted by citations
IL-6 in inflammation, autoimmunity and cancer
Hirano, T. (2021) · International Immunology · doi:10.1093/intimm/dxaa078 · Cited by 1,453
Self-citationOsteoimmunology: evolving concepts in bone–immune interactions in health and disease
Tsukasaki, M., & Takayanagi, H. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0178-8 · Cited by 812
Mechanisms of joint destruction in rheumatoid arthritis — immune cell–fibroblast–bone interactions
Komatsu, N., & Takayanagi, H. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00793-5 · Cited by 574
Pleiotropy and specificity: insights from the interleukin 6 family of cytokines
Murakami, M., Kamimura, D., & Hirano, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.027 · Cited by 533
Self-citationOgura, H., Murakami, M., Okuyama, Y., Tsuruoka, M., Kitabayashi, C., Kanamoto, M., Nishihara, M., Iwakura, Y., & Hirano, T. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.018 · Cited by 564
“We first investigated the roles of IL-17A and IL-6 signaling in fibroblasts because we previously used chimeric mice with transplanted bone-marrow cells to show that the F759 mutation in nonhematopoietic cells but not in hematopoietic cells results in spontaneous autoimmune arthritis (Sawa et al., 2006).”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Sawa, S.-I., Kamimura, D., Jin, G.-H., Morikawa, H., Kamon, H., Nishihara, M., Ishihara, K., Murakami, M., & Hirano, T.
- Affiliations
- 1Laboratory of Developmental Immunology, Graduate School of Frontier Bioscience and Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan
- RIKEN (JP)
- The University of Osaka (JP)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-05-22
- Volume
- 203
- Issue
- 6
- Pages
- 1459-1470
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118324
- OpenAlex
- W2133947803
- Cited by
- 176
- References
- 49
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 4 · 2020: 3 · 2019: 7 · 2018: 7 · 2017: 8 · 2016: 6 · 2015: 16 · 2014: 8 · 2013: 9 · 2012: 19
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- autoimmune arthritis, gp130, IL-6 receptor, STAT3, IL-7, IL-6 family cytokines, MHC class II-restricted T cells, non-hematopoietic cells
- MeSH terms
- Animals, Arthritis, Autoimmune Diseases, Disease Models, Animal, Flow Cytometry, Homeostasis, Homozygote, Humans, Lymphocyte Activation, Mice, Inbred C57BL, Mutation, Thymectomy, CD4-Positive T-Lymphocytes, Interleukin-7, STAT3 Transcription Factor, Cytokine Receptor gp130, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review